Guangdong Lifestrong Pharmacy Co., Ltd. (SZSE: 301111)
Health Care · Pharmaceuticals · CN
CN¥21.73
+6.73% today · +24.0% 1Y
Guangdong Lifestrong Pharmacy Co., Ltd. (SZSE: 301111) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $517.20M and employs 578 people.
Over the last twelve months the share price has gained 24.0%, trading between 15.08 and 31.36.
Tweenvest scores Guangdong Lifestrong Pharmacy Co., Ltd. across four factors: quality 65/100, value 70/100, growth 35/100, dividend 9/100. Its strongest factor is value.
301111 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $517.20M
- Revenue (TTM)
- $44.95M
- P/E
- —
- EPS
- -0.03
- Dividend yield
- 0.23%
- Beta (5Y)
- 0.94
- 52-week high
- CN¥31.36
- 52-week low
- CN¥15.08
- Avg volume (3M)
- —
- Shares outstanding
- 160.00M
- Employees
- 578
- Next earnings
- —
About Guangdong Lifestrong Pharmacy Co., Ltd.
Guangdong Lifestrong Pharmacy Co., Ltd. is a pharmaceutical company primarily involved in the research, development, manufacturing, and sales of various medical products. Its extensive product range includes different dosage forms such as tablets, pills, injections, mixtures, and granules. The company's therapeutic areas of focus encompass respiratory conditions, pediatric care, gynecology, urinary tract health, and nutritional and general healthcare solutions. This enterprise was established in 1951 and operates out of Shantou, China.
- Founded
- 1951
- Listed since
- Dec 7, 2021
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.75 | +0.19% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $153.56 | +0.66% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.